Cargando…
A Rare Case of Levetiracetam-Induced Refractory Hypokalemia
Levetiracetam is a Food and Drug Administration (FDA)-approved drug for partial, generalized, and myoclonic seizures. Its mechanism of action as an antiepileptic involves the release of neurotransmitters from synaptic vesicles. The common side effects of levetiracetam include sleepiness, weakness, d...
Autores principales: | Coughlin, Paige, Patel, Goonja, Vadaketh, Jessica, Pandit, Ramesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067888/ https://www.ncbi.nlm.nih.gov/pubmed/35530900 http://dx.doi.org/10.7759/cureus.23817 |
Ejemplares similares
-
Rhabdomyolysis: A Rare Adverse Effect of Levetiracetam
por: Rastogi, Vaibhav, et al.
Publicado: (2018) -
Refractory Hypokalemia in Secretory Diarrhea Phenotype of Colonic Pseudo-Obstruction (Ogilvie's Syndrome)
por: Hazzazi, Ahmad A, et al.
Publicado: (2022) -
Geller Syndrome: A Rare Cause of Persistent Hypokalemia During Pregnancy
por: Hindosh, Naif, et al.
Publicado: (2022) -
Four Cases of Suspected Levetiracetam-Induced Asymptomatic Rhabdomyolysis
por: Saito, Satoshi, et al.
Publicado: (2023) -
Endoscopic Full-Thickness Resection for the Management of a Polyp in a Patient With Ulcerative Colitis
por: Baker, Gianna, et al.
Publicado: (2022)